<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39438126</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1468-3288</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>10</Day></PubDate></JournalIssue><Title>Gut</Title><ISOAbbreviation>Gut</ISOAbbreviation></Journal><ArticleTitle>Combined MRI, high-resolution manometry and a randomised trial of bisacodyl versus hyoscine show the significance of an enlarged colon in constipation: the RECLAIM study.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>44</EndPage><MedlinePgn>35-44</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e332755</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/gutjnl-2024-332755</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Colonic motility in constipation can be assessed non-invasively using MRI.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare MRI with high-resolution colonic manometry (HRCM) for predicting treatment response.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Part 1: 44 healthy volunteers (HVs), 43 patients with irritable bowel syndrome with constipation (IBS-C) and 37 with functional constipation (FC) completed stool diaries and questionnaires and underwent oral macrogol (500-1000&#x2009;mL) challenge. Whole gut transit time (WGTT), segmental colonic volumes (CV), MRI-derived Motility Index and chyme movement by 'tagging' were assessed using MRI and time to defecation after macrogol recorded. Left colonic HRCM was recorded before and after a 700 kcal meal. Patients then proceeded to Part 2: a randomised cross-over study of 10-days bisacodyl 10&#x2009;mg daily versus hyoscine 20&#x2009;mg three times per day, assessing daily pain and constipation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Part 1: Total CVs median (range) were significantly greater in IBS-C (776 (595-1033)) and FC (802 (633-951)) vs HV (645 (467-780)), p&lt;0.001. Patients also had longer WGTT and delayed evacuation after macrogol. IBS-C patients showed significantly reduced tagging index and less propagated pressure wave (PPW) activity during HRCM versus HV. Compared with FC, IBS-C patients were more anxious and reported more pain. Abnormally large colons predicted significantly delayed evacuation after macrogol challenge (p&lt;0.02), impaired manometric meal response and reduced pain with bisacodyl (p&lt;0.05).Part 2: Bisacodyl compared with hyoscine increased bowel movements but caused more pain in both groups (p&lt;0.03).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An abnormally large colon is an important feature in constipation which predicts impaired manometric response to feeding and treatment responses. HRCM shows that IBS-C patients have reduced PPW activity.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">The study was preregistered on ClinicalTrials.gov, Reference: NCT03226145.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilkinson-Smith</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Mark</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7997-1533</Identifier><AffiliationInfo><Affiliation>Academic Surgical Unit, Barts and The London School of Medicine and Dentistry, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menys</LastName><ForeName>Alex</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6088-0730</Identifier><AffiliationInfo><Affiliation>Motilent Ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiklendt</LastName><ForeName>Lukasz</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8152-3070</Identifier><AffiliationInfo><Affiliation>College of Medicine &amp; Public Health, Flinders University, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marciani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9092-4300</Identifier><AffiliationInfo><Affiliation>Translational Medical Sciences, Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nottingham Digestive Diseases Centre, NIHR Nottingham Biomedical Research Centre, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkinson</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1124-6666</Identifier><AffiliationInfo><Affiliation>Centre for Medical Imaging, UCL, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sansone</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2276-5819</Identifier><AffiliationInfo><Affiliation>Nottingham Digestive Diseases Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zdanaviciene</LastName><ForeName>Ausra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0003-7374-6006</Identifier><AffiliationInfo><Affiliation>Barts and the London School of Medicine and Dentistry, Queen Mary University, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coupland</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2327-3306</Identifier><AffiliationInfo><Affiliation>Centre for Academic Primary Care, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knowles</LastName><ForeName>Charles H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0001-9854-6754</Identifier><AffiliationInfo><Affiliation>Blizzard Institute, Queen Mary University, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dinning</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8910-2801</Identifier><AffiliationInfo><Affiliation>Gastroenterology and Surgery, Flinders Medical Center, Adelaide, South Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Stuart A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-6765-8806</Identifier><AffiliationInfo><Affiliation>Imaging Department, University College London Hospitals NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gowland</LastName><ForeName>Penny</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4900-4817</Identifier><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sir Peter Mansfield Magnetic Resonance Centre, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoad</LastName><ForeName>Caroline Louise</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0001-5483-1027</Identifier><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sir Peter Mansfield Magnetic Resonance Centre, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corsetti</LastName><ForeName>Maura</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2957-4684</Identifier><AffiliationInfo><Affiliation>NIHR Nottingham Biomedical Research Centre, Nottingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nottingham Digestive Diseases Biomedical Research Unit, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiller</LastName><ForeName>Robin C</ForeName><Initials>RC</Initials><Identifier Source="ORCID">0000-0001-6371-4500</Identifier><AffiliationInfo><Affiliation>Nottingham Digestive Diseases Centre, NIHR Nottingham Biomedical Research Centre, Nottingham, UK robin.spiller@nottingham.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Medical Science, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03226145</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gut</MedlineTA><NlmUniqueID>2985108R</NlmUniqueID><ISSNLinking>0017-5749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>10X0709Y6I</RegistryNumber><NameOfSubstance UI="D001726">Bisacodyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003248" MajorTopicYN="Y">Constipation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008365" MajorTopicYN="Y">Manometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001726" MajorTopicYN="Y">Bisacodyl</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="Y">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="Y">Colon</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005769" MajorTopicYN="N">Gastrointestinal Motility</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005772" MajorTopicYN="N">Gastrointestinal Transit</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COLORECTAL MOTILITY</Keyword><Keyword MajorTopicYN="N">COLORECTAL PHYSIOLOGY</Keyword><Keyword MajorTopicYN="N">CONSTIPATION</Keyword><Keyword MajorTopicYN="N">LAXATIVES</Keyword></KeywordList><CoiStatement>Competing interests: RCS: Grants/research supports: Sanofi-Aventis Deutschland, Nestle Consultant to Enterobiotix. MC: Consultant: Sanofi, Takeda, Biocodex, Mayoly. SMS: honoraria for teaching for the Laborie Group. SAT: grant support from Takeda. Consultancy fees AstraZeneca, Sanofi-Aventis. Share holder Motilent.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>11</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>21</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39438126</ArticleId><ArticleId IdType="pmc">PMC11671975</ArticleId><ArticleId IdType="doi">10.1136/gutjnl-2024-332755</ArticleId><ArticleId IdType="pii">gutjnl-2024-332755</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582&#x2013;91. doi: 10.1038/ajg.2011.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2011.164</ArticleId><ArticleId IdType="pubmed">21606976</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2020;160:99&#x2013;114. doi: 10.1053/j.gastro.2020.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.04.014</ArticleId><ArticleId IdType="pubmed">32294476</ArticleId></ArticleIdList></Reference><Reference><Citation>Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology. 2016 doi: 10.1053/j.gastro.2016.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.02.031</ArticleId><ArticleId IdType="pubmed">27144627</ArticleId></ArticleIdList></Reference><Reference><Citation>Palsson OS, Baggish JS, Turner MJ, et al. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol. 2012;107:286&#x2013;95. doi: 10.1038/ajg.2011.358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2011.358</ArticleId><ArticleId IdType="pmc">PMC3855407</ArticleId><ArticleId IdType="pubmed">22068664</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford AC, Bercik P, Morgan DG, et al. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther. 2014;39:312&#x2013;21. doi: 10.1111/apt.12573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.12573</ArticleId><ArticleId IdType="pubmed">24308816</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekhar C, Monaghan PJ, Morris J, et al. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology. 2013;145:749&#x2013;57. doi: 10.1053/j.gastro.2013.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2013.07.014</ArticleId><ArticleId IdType="pubmed">23872499</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott SM, Simr&#xe9;n M, Farmer AD, et al. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation. Neurogastroenterol Motil. 2021;33:e14050. doi: 10.1111/nmo.14050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14050</ArticleId><ArticleId IdType="pubmed">33263938</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong RK, Palsson OS, Turner MJ, et al. Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol. 2010;105:2228&#x2013;34. doi: 10.1038/ajg.2010.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2010.200</ArticleId><ArticleId IdType="pmc">PMC3786710</ArticleId><ArticleId IdType="pubmed">20502449</ArticleId></ArticleIdList></Reference><Reference><Citation>Serra J, Pohl D, Azpiroz F, et al. European society of neurogastroenterology and motility guidelines on functional constipation in adults. Neurogastroenterology Motil. 2020;32:e13762. doi: 10.1111/nmo.13762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13762</ArticleId><ArticleId IdType="pubmed">31756783</ArticleId></ArticleIdList></Reference><Reference><Citation>Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007;25:599&#x2013;608. doi: 10.1111/j.1365-2036.2006.03238.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2006.03238.x</ArticleId><ArticleId IdType="pubmed">17305761</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam C, Chaddock G, Marciani L, et al. Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation. Neurogastroenterol Motil. 2016;28:861&#x2013;70. doi: 10.1111/nmo.12784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12784</ArticleId><ArticleId IdType="pmc">PMC4949702</ArticleId><ArticleId IdType="pubmed">26871949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson-Smith V, Menys A, Bradley C, et al. The MRI colonic function test: Reproducibility of the Macrogol stimulus challenge. Neurogastroenterol Motil. 2020;32:e13942. doi: 10.1111/nmo.13942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13942</ArticleId><ArticleId IdType="pubmed">32677154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaddock G, Lam C, Hoad CL, et al. Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects. Neurogastroenterol Motil. 2014;26:205&#x2013;14. doi: 10.1111/nmo.12249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12249</ArticleId><ArticleId IdType="pmc">PMC4285997</ArticleId><ArticleId IdType="pubmed">24165044</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard SE, Paul J, Major G, et al. Assessment of motion of colonic contents in the human colon using MRI tagging. Neurogastroenterol Motil. 2017;29 doi: 10.1111/nmo.13091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13091</ArticleId><ArticleId IdType="pubmed">28439942</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinning PG, Wiklendt L, Maslen L, et al. Quantification of in vivo colonic motor patterns in healthy humans before and after a meal revealed by high-resolution fiber-optic manometry. Neurogastroenterol Motil. 2014;26:1443&#x2013;57. doi: 10.1111/nmo.12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12408</ArticleId><ArticleId IdType="pmc">PMC4438670</ArticleId><ArticleId IdType="pubmed">25131177</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinning PG, Wiklendt L, Maslen L, et al. Colonic motor abnormalities in slow transit constipation defined by high resolution, fibre-optic manometry. Neurogastroenterol Motil. 2015;27:379&#x2013;88. doi: 10.1111/nmo.12502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12502</ArticleId><ArticleId IdType="pubmed">25557630</ArticleId></ArticleIdList></Reference><Reference><Citation>Slappendel R, Simpson K, Dubois D, et al. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain. 2006;10:209&#x2013;17. doi: 10.1016/j.ejpain.2005.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpain.2005.03.008</ArticleId><ArticleId IdType="pubmed">15914049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad CL, Menys A, Garsed K, et al. Colon wall motility: comparison of novel quantitative semi-automatic measurements using cine MRI. Neurogastroenterol Motil. 2016;28:327&#x2013;35. doi: 10.1111/nmo.12727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12727</ArticleId><ArticleId IdType="pubmed">26612075</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshammari MT, Alyami AS, Wilkinson-Smith V, et al. MRI tagging of colonic chyme mixing in healthy subjects: Inter-observer variability and reliability of the measurement with time. Neurogastroenterol Motil. 2023;35:e14610. doi: 10.1111/nmo.14610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.14610</ArticleId><ArticleId IdType="pubmed">37158374</ArticleId></ArticleIdList></Reference><Reference><Citation>Corsetti M, Pagliaro G, Demedts I, et al. Pan-Colonic Pressurizations Associated With Relaxation of the Anal Sphincter in Health and Disease: A New Colonic Motor Pattern Identified Using High-Resolution Manometry. Am J Gastroenterol. 2017;112:479&#x2013;89. doi: 10.1038/ajg.2016.341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2016.341</ArticleId><ArticleId IdType="pubmed">27596695</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiklendt L, Costa M, Scott MS, et al. Automated Analysis Using a Bayesian Functional Mixed-Effects Model With Gaussian Process Responses for Wavelet Spectra of Spatiotemporal Colonic Manometry Signals. Front Physiol. 2023;11:605066. doi: 10.3389/fphys.2020.605066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.605066</ArticleId><ArticleId IdType="pmc">PMC7905106</ArticleId><ArticleId IdType="pubmed">33643057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiklendt L, Costa M, Scott MS, et al. Automated Analysis Using a Bayesian Functional Mixed-Effects Model With Gaussian Process Responses for Wavelet Spectra of Spatiotemporal Colonic Manometry Signals. Front Physiol. 2020;11:605066. doi: 10.3389/fphys.2020.605066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.605066</ArticleId><ArticleId IdType="pmc">PMC7905106</ArticleId><ArticleId IdType="pubmed">33643057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S, Lembo AJ, Shiff SJ, et al. A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation. Am J Gastroenterol. 2012;107:1714&#x2013;24. doi: 10.1038/ajg.2012.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2012.255</ArticleId><ArticleId IdType="pmc">PMC3504311</ArticleId><ArticleId IdType="pubmed">22986440</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannakou Y, Tack J, Piessevaux H, et al. The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference. Aliment Pharmacol Ther. 2017;46:1103&#x2013;11. doi: 10.1111/apt.14349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.14349</ArticleId><ArticleId IdType="pmc">PMC5698746</ArticleId><ArticleId IdType="pubmed">28983926</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppen IJN, Thompson BP, Ambeba EJ, et al. Segmental colonic dilation is associated with premature termination of high-amplitude propagating contractions in children with intractable functional constipation. Neurogastroenterol Motil. 2017;29:1&#x2013;9. doi: 10.1111/nmo.13110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13110</ArticleId><ArticleId IdType="pubmed">28524640</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollebregt PF, Burgell RE, Knowles CH, et al. Rectal Hyposensitivity Is an Important Pathophysiologic Mechanism in Patients With Constipation: Evidence From Large Observational Studies in Patients Referred for Anorectal Physiology Testing. Am J Gastroenterol. 2022;117:688. doi: 10.14309/ajg.0000000000001633.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001633</ArticleId><ArticleId IdType="pubmed">35080515</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M, Pandey A, Li D, et al. Constipated patients with functional defecatory disorder have secondary rectal hyposensitivity due to altered rectal biomechanics. J Gastroenterol Hepatol. 2024;39:1082&#x2013;7. doi: 10.1111/jgh.16517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.16517</ArticleId><ArticleId IdType="pubmed">38418424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattuso JM, Kamm MA. Clinical features of idiopathic megarectum and idiopathic megacolon. Gut. 1997;41:93&#x2013;9. doi: 10.1136/gut.41.1.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.41.1.93</ArticleId><ArticleId IdType="pmc">PMC1027235</ArticleId><ArticleId IdType="pubmed">9274479</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells CI, Paskaranandavadivel N, Lin AY, et al. Development and feasibility of an ambulatory acquisition system for fiber&#x2010;optic high&#x2010;resolution colonic manometry. Neurogastroenterol Motil. 2019;31 doi: 10.1111/nmo.13704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.13704</ArticleId><ArticleId IdType="pubmed">31407459</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassotti G, Gaburri M. Manometric investigation of high-amplitude propagated contractile activity of the human colon. Am J Physiol. 1988;255:G660&#x2013;4. doi: 10.1152/ajpgi.1988.255.5.G660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.1988.255.5.G660</ArticleId><ArticleId IdType="pubmed">3189553</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#xe8;xia A, Abdulsalam A, Neele D, et al. Magnetic resonance imaging (MRI) studies of single and multiple doses of bisacodyl demonstrate impact on both colonic motility and small bowel and colonic water content. U Eur Gastroenterol J. 2023;OP223</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>